Latest Advances

  • Condition: Generalized Granuloma Annulare
  • Journal: Dermatology (Basel, Switzerland)
  • Treatment Used: Topical Corticosteroids as First-Line Treatment, Intralesional Triamcinolone Acetonide for Persistent Solitary Lesions
  • Number of Patients: 61
  • Published —
This study described disease characteristics, treatment outcome and associated diseases in patients treated for granuloma annulare, a chronic noninfectious granulomatous skin condition, with topical corticosteroids as the first-line treatment, and intralesional triamcinolone acetonide for persistent solitary lesions.
  • Condition: Subcutaneous Granuloma Annulare on Heel
  • Journal: The Journal of dermatology
  • Treatment Used: Avoiding Invasive Treatment
  • Number of Patients: 86
  • Published —
This case report discusses a 5-year-old Japanese girl with subcutaneous granuloma annulare (bumps) on the right heel.
  • Condition: Granuloma Annulare
  • Journal: International journal of dermatology
  • Treatment Used: Biologics
  • Number of Patients: 0
  • Published —
Granuloma annulare (GA) is a benign inflammatory skin disease. The purpose of this study was to evaluate the effectiveness of various biologics in treating granuloma annulare.
  • Condition: Cutaneous Inflammatory Disorders
  • Journal: Dermatology (Basel, Switzerland)
  • Treatment Used: Potassium Iodide
  • Number of Patients: 35
  • Published —
This study evaluated the outcomes of potassium iodide therapy in patients with cutaneous inflammatory disorders.
  • Condition: Generalized Granuloma Annulare
  • Journal: The Journal of dermatological treatment
  • Treatment Used: Methotrexate
  • Number of Patients: 11
  • Published —
This study tested the safety and efficacy of using methotrexate to treat patients with generalized granuloma annulare.
  • Condition: Annular Elastolytic Giant Cell Granuloma Complicated by Drug-Induced Lupus
  • Journal: Journal of drugs in dermatology : JDD
  • Treatment Used: Adalimumab
  • Number of Patients: 1
  • Published —
This case report describes a 51-year-old female with a recalcitrant annular elastolytic giant cell granuloma (AEGCG) treated with the anti-tumor necrosis factor (TNF)-alpha antibody, adalimumab, who developed a positive anti-nuclear-antibody and double-stranded-DNA antibody.
Showing 1-6 of 6